BioXcel Therapeutics
Public company
BIOXCEL THERAPEUTICS
BioXcel Therapeutics is a clinical stage biopharmaceutical company that utilizes novel artificial intelligence, or AI, to identify the next wave of medicines across neuroscience and immuno-oncology.
Founded
2017
2017
Status
Public company
Public company
Geography
United States of America based
United States of America based
Funding
$69 M
$69 M
Patents
7
7
Clinical Trials
6
6
Products
No products posted yet
Services
No services posted yet
This data is part of our proprietary analytics report: